Germany
Japan
United Kingdom
China
Products
View as table Download
ERK2 Rabbit polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 200-300 of human ERK2 (NP_620407.1). |
| Modifications | Unmodified |
ERK1 / ERK2 Rabbit polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 200-300 of human ERK1 / ERK2 (NP_620407.1/NP_002737.2). |
| Modifications | Unmodified |
MAPK1/MAPK3 Rabbit polyclonal Antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant Protein of human MAPK1/MAPK3 |
| Modifications | Unmodified |
Phospho-ERK1-T202/Y204 + ERK2-T185/Y187 Rabbit polyclonal Antibody
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic phosphorylated peptide around T185/Y187 of human ERK2 (NP_002736.3). |
| Modifications | Phospho T202/Y204 + T185/Y187 |
ERK2 Rabbit polyclonal Antibody
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthesized peptide derived from human ERK2 |
ERK2 Rabbit monoclonal Antibody
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 420.00
4 Weeks
USD 420.00
4 Weeks
USD 420.00
5 Days
USD 420.00
5 Days
USD 420.00
5 Days
USD 420.00
5 Days
Active filters
Target Symbol
- MAPK1
Applications
- IF
Filter by
Category
Reactivities
Antibody Hosts
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Families
Pathways
- Acute myeloid leukemia (17)
- Adherens junction (17)
- Alzheimer's disease (17)
- Axon guidance (17)
- B cell receptor signaling pathway (17)
- Bladder cancer (17)
- Chemokine signaling pathway (17)
- Chronic myeloid leukemia (17)
- Colorectal cancer (17)
- Dorso-ventral axis formation (17)
- Endometrial cancer (17)
- ErbB signaling pathway (17)
- Fc epsilon RI signaling pathway (17)
- Fc gamma R-mediated phagocytosis (17)
- Focal adhesion (17)
- Gap junction (17)
- Glioma (17)
- GnRH signaling pathway (17)
- Insulin signaling pathway (17)
- Long-term depression (17)
- Long-term potentiation (17)
- MAPK signaling pathway (17)
- Melanogenesis (17)
- Melanoma (17)
- NOD-like receptor signaling pathway (17)
- Natural killer cell mediated cytotoxicity (17)
- Neurotrophin signaling pathway (17)
- Non-small cell lung cancer (17)
- Oocyte meiosis (17)
- Pancreatic cancer (17)
- Pathways in cancer (17)
- Prion diseases (17)
- Progesterone-mediated oocyte maturation (17)
- Prostate cancer (17)
- Regulation of actin cytoskeleton (17)
- Renal cell carcinoma (17)
- T cell receptor signaling pathway (17)
- TGF-beta signaling pathway (17)
- Thyroid cancer (17)
- Toll-like receptor signaling pathway (17)
- Type II diabetes mellitus (17)
- VEGF signaling pathway (17)
- Vascular smooth muscle contraction (17)
- mTOR signaling pathway (17)